Literature DB >> 11440201

Rat strain differences in responses of plasma prolactin and PRL mRNA expression after acute amphetamine treatment or restraint stress.

V Klenerova1, P Sida, S Hynie, J Jurcovicova.   

Abstract

1. The aim of this study was to compare the effects of acute amphetamine (AMPH) treatment and restraint stress on plasma level of prolactin (PRL) and PRL mRNA expression in the adenohypophysis in Sprague-Dawley and Lewis male rats, the latter known to have a deficient hypothalamo-pituitary-adrenal (HPA) axis. 2. Both restraint stress and AMPH treatment (i.p. in a dose of 8 mg/kg of b.w.) were applied 15 or 30 min before termination of the experiment. Plasma PRL and corticosterone (CORT) were determined by radioimmunoassay. PRL mRNA expression was estimated by a dot-blot hybridization. 3. Restraint stress and AMPH treatment induced a significant increase in the CORT plasma level, as an indicator of stress response. Compared to Sprague-Dawley rats, the magnitude of CORT increase after both stimuli was significantly lower in Lewis rats. 4. Although restraint stress significantly increased the PRL plasma levels in both rat strains, AMPH treatment reduced the PRL levels in both rat strains. However, the changes of PRL plasma levels had another pattern in Lewis rats than in Sprague-Dawley rats. Control plasma PRL levels were significantly higher in Lewis rats, and in this rat strain AMPH treatment for 30 min increased the PRL levels as compared to the values obtained after AMPH treatment for 15 min. 5. Expression of PRL mRNA in adenohypophysis by restraint stress and AMPH treatment had a similar pattern. After a 15-min lasting restraint stress, the expression of PRL mRNA was decreased insignificantly in both rat strains. AMPH treatment induced in Sprague-Dawley rats a significant decrease of PRL mRNA after a 15-min interval while after 30 min there was a significant increase. However, in Lewis rats AMPH failed to significantly change PRL mRNA. 6. The results from the present study indicate that the mechanisms mediating the effects of acute restraint stress and acute AMPH treatment differ in PRL response in Sprague-Dawley and Lewis male rat strains. Differences in the observed responses in Lewis rats could be related to the deficient activity of HPA axis in this rat strain.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11440201     DOI: 10.1023/a:1007177430146

Source DB:  PubMed          Journal:  Cell Mol Neurobiol        ISSN: 0272-4340            Impact factor:   5.046


  26 in total

Review 1.  The dopamine hypothesis of reward: past and current status.

Authors:  R Spanagel; F Weiss
Journal:  Trends Neurosci       Date:  1999-11       Impact factor: 13.837

2.  Glucocorticoid negative feedback on the HPA axis in five inbred rat strains.

Authors:  F Gómez; E R De Kloet; A Armario
Journal:  Am J Physiol       Date:  1998-02

3.  Influence of age on stress responses to metabolic cage housing in rats.

Authors:  M C Gil; J A Aguirre; A P Lemoine; E T Segura; M Barontini; I Armando
Journal:  Cell Mol Neurobiol       Date:  1999-10       Impact factor: 5.046

4.  Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family.

Authors:  P Fort; L Marty; M Piechaczyk; S el Sabrouty; C Dani; P Jeanteur; J M Blanchard
Journal:  Nucleic Acids Res       Date:  1985-03-11       Impact factor: 16.971

5.  Adaptation to prolonged or repeated stress--comparison between rat strains showing intrinsic differences in reactivity to acute stress.

Authors:  F S Dhabhar; B S McEwen; R L Spencer
Journal:  Neuroendocrinology       Date:  1997-05       Impact factor: 4.914

6.  Neurotransmitter-induced hypothalamic-pituitary-adrenal axis responsiveness is defective in inflammatory disease-susceptible Lewis rats: in vivo and in vitro studies suggesting globally defective hypothalamic secretion of corticotropin-releasing hormone.

Authors:  A E Calogero; E M Sternberg; G Bagdy; C Smith; R Bernardini; S Aksentijevich; R L Wilder; P W Gold; G P Chrousos
Journal:  Neuroendocrinology       Date:  1992-05       Impact factor: 4.914

7.  The prolactin response to d- and l-fenfluramine and to d-amphetamine in human subjects.

Authors:  S Feeney; E Goodall; T Silverstone
Journal:  Int Clin Psychopharmacol       Date:  1993       Impact factor: 1.659

8.  Suppression of adjuvant arthritis in rats with chronic bromocriptine treatment does not prevent associated oxidative stress.

Authors:  J Jurcovicova; K Svik; J Rovensky; M Stancikova; S Zorad; I Konecna; V Holecek; L Trefil; J Racek; R Rokyta
Journal:  Int J Immunopathol Pharmacol       Date:  2000 Jan-Apr       Impact factor: 3.219

9.  Effect of amphetamine on brain catecholamines, brain beta-endorphin, serum prolactin, catechol-O-methyltransferase and monoamine oxidase of various organs in the rat.

Authors:  D P Agarwal; J J Hoo; A Tjaden; I Nishigaki; W J Beckermann; V Pahnke; H W Goedde
Journal:  Arzneimittelforschung       Date:  1985

10.  Brain corticotropin-releasing factor immunoreactivity and receptors in five inbred rat strains: relationship to forced swimming behaviour.

Authors:  A Lahmame; D E Grigoriadis; E B De Souza; A Armario
Journal:  Brain Res       Date:  1997-03-07       Impact factor: 3.252

View more
  3 in total

1.  Effects of handling and vehicle injections on adrenocorticotropic and corticosterone concentrations in Sprague-Dawley compared with Lewis rats.

Authors:  Molly Deutsch-Feldman; Roberto Picetti; Katharine Seip-Cammack; Yan Zhou; Mary Jeanne Kreek
Journal:  J Am Assoc Lab Anim Sci       Date:  2015-01       Impact factor: 1.232

2.  Social buffering in rats: prolactin attenuation of active interaction.

Authors:  Salvatore P Insana; Janie H Wilson
Journal:  Psychol Rep       Date:  2008-08

3.  Involvement of the central hypothalamic-pituitary-adrenal axis in hair growth and melanogenesis among different mouse strains.

Authors:  Qian Wang; Huali Wu; Jia Zhou; Siran Pei; Jing Li; Yuanyuan Cai; Jing Shang
Journal:  PLoS One       Date:  2018-10-24       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.